Deccan Health Care Annual Report FY25-26: Revenue up 18.7%, PAT up 91%
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.2 pts more than Nifty Microcap 250 and 3.0 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Deccan Health Care posted FY25-26 standalone revenue of Rs 8,917.97 lakhs (up 18.7%) and net profit of Rs 229.04 lakhs (up 91.2%). EPS rose 66.1% to Rs 0.93. Consolidated PAT jumped 114.7% to Rs 248.76 lakhs. EBITDA grew 46.7% with margins improving from 1.59% to 2.57%. The nutraceutical firm expanded digital platforms, launched multiple products, and entered UAE and African markets. 30th AGM set for 30 September 2026 via video conferencing.
Strong double-digit revenue and triple-digit profit growth signal improved efficiency and global expansion momentum for shareholders.